ArticleWorld journal of clinical oncology2015

Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck.

Michael Mix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.